Compare FirstEnergy Corp. (FE) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs ResMed Inc. — how do they compare? FirstEnergy Corp. trades at $45 (market cap $25.95B), while ResMed Inc. trades at $230.12 (market cap $31.89B). The key difference: ResMed Inc. is the larger of the two by market cap, and FirstEnergy Corp. pays the higher dividend (4.15%). Which is the better fit depends on your goals — on Pluang, investors hold FirstEnergy Corp. for 71 Days and ResMed Inc. for 51 Days on average.
| FE | RMD | |
|---|---|---|
Market Cap | $25.95B | $31.89B |
Volume | 5,643,833 | 618,314 |
Sector | Utilities | Health |
52-Week High | $51.91 | $277.88 |
52-Week Low | $43.04 | $182.82 |
Typical Hold Time | 71 Days | 51 Days |
Enterprise Value | $54.87B | $31.24B |
Dividend Yield | 4.15% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $45.00, up 0.94% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.50, slightly missing expectations, while Q1 beat estimates. Revenue growth has been steady, reaching $15.09B in 2025, with a net income margin of 6.86%. Recent developments include the Energize365 investment plan and consistent dividend payments, supporting long-term growth prospects amid utility sector stability.
Outlook remains cautiously optimistic with a consensus price target of $52.80, representing 17% upside potential. Risks include high debt levels ($24.03B total debt) and regulatory challenges, but strong institutional ownership and analyst buy ratings (42.86%) provide support. The stock offers dividend income with recent declarations of $0.47 per share, appealing to income-focused investors in the electric utility sector.
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
